China Holds Meeting On H7N9 Spread Control; 18 Contracted; 6 Dead Yet
This article was originally published in PharmAsia News
Executive Summary
China’s National Health and Family Planning Commission held a midnight meeting April 7 to discuss measures to contain the spread of H7N9 virus with at least 18 contraction cases reported earlier this week, including eight in Shanghai, three in Jiangsu, one in Anhui.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.